Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics

被引:10
作者
Delahousse, B
Maillot, F
Gabriel, I
Schellenberg, F
Lamisse, F
Gruel, Y [1 ]
机构
[1] Hop Trousseau, Serv Hematol Hemostase, Biochim Lab, F-37044 Tours, France
[2] Hop Bretonneau, Clin Med A, Tours, France
[3] Univ Tours, Lab Nutr, Tours, France
[4] Ctr Cure Louis Sevestre, La Membrolle Choiselle, France
关键词
fibrinolysis; alcohol; tissue-type plasminogen activator; plasminogen activator inhibitor;
D O I
10.1097/00001721-200101000-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of alcohol withdrawal on fibrinolysis were studied in 10 middle-aged male chronic alcoholics institutionalized for withdrawal therapy. All patients were sampled on admission [day 1 (D1)] and 21 days after alcohol withdrawal [day 22 (D22)]. The overall plasma fibrinolytic capacity (OFC) was assayed by measuring the ability of patient plasma to generate D-dimers from a standardized fibrin clot, and tissue-type plasminogen activator (t-PA) and t-PA inhibitor (PAI-1) levels were assayed together with serum cholesterol, triglyceride and cholesterol fractions. At D22, the OFC significantly increased in seven patients [D1 = 10 +/- 0.7 mug/h (mean +/- SD), D22 = 17 +/- 7.4 mug/h; P < 0.01], while t-PA and PAI-I levels decreased in all patients but two (tPA: D1 = 16.6 +/-5 ng/ml, D22 = 10.2 +/- 3.8 ng/ml; P < 0.001; and PAI-I: D1 = 46 rt 39 ng/ml, D22 = 21 +/- 28 ng/ml; P < 0.01). This study clearly demonstrates an increase in overall fibrinolytic activity after alcohol withdrawal, which is mainly due to a decrease in PAI-1 levels. These changes induced by alcohol abstinence might provide clear benefit by reducing the risk of thromboembolic events and particularly of stroke associated with elevated PAI-1 levels described in heavy drinkers. Blood Coagul Fibrinolysis 12:59-66 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 26 条
[1]  
Amiral J, 1999, FIBRINOLYSIS PROTEOL, V13, P1
[2]   RELATIONSHIP BETWEEN PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY AND VLDL TRIGLYCERIDE CONCENTRATION, INSULIN LEVELS AND INSULIN SENSITIVITY - STUDIES IN RANDOMLY SELECTED NORMOTRIGLYCERIDAEMIC AND HYPERTRIGLYCERIDEMIC MEN [J].
ASPLUNDCARLSON, A ;
HAMSTEN, A ;
WIMAN, B ;
CARLSON, LA .
DIABETOLOGIA, 1993, 36 (09) :817-825
[3]  
AZNAR J, 1988, BRIT HEART J, V59, P535
[4]   The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial [J].
Dimmitt, SB ;
Rakic, V ;
Puddey, IB ;
Baker, R ;
Oostryck, R ;
Adams, MJ ;
Chesterman, CN ;
Burke, V ;
Beilin, LJ .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (01) :39-45
[5]   Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia [J].
Eriksson, P ;
Nilsson, L ;
Karpe, F ;
Hamsten, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (01) :20-26
[6]   MODERATE ALCOHOL INTAKE, INCREASED LEVELS OF HIGH-DENSITY-LIPOPROTEIN AND ITS SUBFRACTIONS, AND DECREASED RISK OF MYOCARDIAL-INFARCTION [J].
GAZIANO, JM ;
BURING, JE ;
BRESLOW, JL ;
GOLDHABER, SZ ;
ROSNER, B ;
VANDENBURGH, M ;
WILLETT, W ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (25) :1829-1834
[7]   The health benefits of wine [J].
German, JB ;
Walzem, RL .
ANNUAL REVIEW OF NUTRITION, 2000, 20 :561-593
[8]   Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: Results from a prospective cohort study of Scottish men with 21 years of follow up [J].
Hart, CL ;
Smith, GD ;
Hole, DJ ;
Hawthorne, VM .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7200) :1725-1729
[9]   EFFECT OF MODERATE DOSE OF ALCOHOL WITH EVENING MEAL ON FIBRINOLYTIC FACTORS [J].
HENDRIKS, HFJ ;
VEENSTRA, J ;
VELTHUISTEWIERIK, EJM ;
SCHAAFSMA, G ;
KLUFT, C .
BRITISH MEDICAL JOURNAL, 1994, 308 (6935) :1003-1006
[10]  
ISO H, 1993, THROMB HAEMOSTASIS, V70, P475